Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen Revision Vorhergehende Überarbeitung Nächste Überarbeitung | Vorhergehende Überarbeitung | ||
frangula_purshiana_dc._a._gray [2014/11/28 12:30] andreas |
frangula_purshiana_dc._a._gray [2015/06/13 11:38] (aktuell) |
||
---|---|---|---|
Zeile 9: | Zeile 9: | ||
The fresh bark contains free anthrones and must be dried for at least 1 year or artificially aged by heat or aeration before therapeutic use. \\ | The fresh bark contains free anthrones and must be dried for at least 1 year or artificially aged by heat or aeration before therapeutic use. \\ | ||
Contains not less than 8.0% hydroxyanthracene glycosides of which not less than 60% consists of cascarosides, | Contains not less than 8.0% hydroxyanthracene glycosides of which not less than 60% consists of cascarosides, | ||
- | The active constituents are hydroxyanthracene glycosides (6-9%). Of these, 70-90% are C-10 glycosides, with the 8-O-glycosides, | + | The active constituents are hydroxyanthracene glycosides (6-9%). Of these, 70-90% are C-10 glycosides, with the 8 -O-glycosides, |
[Cortex Rhamni Purshianae, WHO Monographs on Selected Medicinal Plants - Volume 2, 2004] [[http:// | [Cortex Rhamni Purshianae, WHO Monographs on Selected Medicinal Plants - Volume 2, 2004] [[http:// | ||